Using this approach, it was reported that the inhibitor of the EWS-FLI1 oncoprotein in Ewing’s Sarcoma (YK-4-279) can downregulate the gene expressions of ERG and ETV1 downstream target genes in ETV1 or ERG fusion-positive prostate cancer cells. Here, ERG is linked to Ewing sarcoma.